Treatment de-escalation for stage II seminoma

Laguna, M. P. et al. EAU guidelines on testicular cancer. EAU https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Testicular-Cancer-2022.pdf (2022).

Cheng, L. et al. Testicular cancer. Nat. Rev. Dis. Primers 4, 29 (2018).

Article  PubMed  Google Scholar 

Oldenburg, J. et al. Testicular seminoma and non-seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24, vi125–vi132 (2013).

Article  PubMed  Google Scholar 

International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a. prognostic factor-based staging system for metastatic germ cell. J. Clin. Oncol. 15, 594–603 (1997).

Article  Google Scholar 

Gillessen, S. et al. Redefining the IGCCCG classification in advanced non-seminoma [abstract 903O]. Ann. Oncol. 30 (Suppl. 5), v357–v358 (2019).

Article  Google Scholar 

Gilligan, T. et al. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J. Natl Compr. Cancer Netw. 17, 1529–1554 (2019).

Article  CAS  Google Scholar 

Cancer Research UK. Testicular cancer incidence statistics. Cancer Research UK https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/testicular-cancer/incidence (2022).

Williams, S. D. et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N. Engl. J. Med. 316, 1435–1440 (1987).

Article  CAS  PubMed  Google Scholar 

Travis, L. B. et al. Testicular cancer survivorship: research strategies and recommendations. J. Natl Cancer Inst. 102, 1114–1130 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Meinardi, M. T. et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J. Clin. Oncol. 18, 1725–1732 (2000).

Article  CAS  PubMed  Google Scholar 

Fung, C. et al. Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors. Adv. Urol. 2018, 8671832 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Amin, M. B. et al. The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 267, 93–99 (2017).

Article  Google Scholar 

Fosså, S. D. et al. Mortality and second cancer incidence after treatment for testicular cancer: psychosocial health and lifestyle are modifiable prognostic factors. J. Clin. Oncol. 40, 2588–2599 (2022).

Article  PubMed  Google Scholar 

O’Sullivan, J. M. et al. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann. Oncol. 14, 91–96 (2003).

Article  PubMed  Google Scholar 

Simpson, A. B., Paul, J., Graham, J. & Kaye, S. B. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours. Br. J. Cancer 78, 1061–1066 (1998).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haugnes, H. S. et al. Pulmonary function in long-term survivors of testicular cancer. J. Clin. Oncol. 27, 2779–2786 (2009).

Article  PubMed  Google Scholar 

Haugnes, H. S., Oldenburg, J. & Bremnes, R. M. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors. Urol. Oncol. 33, 399–406 (2015).

Article  PubMed  Google Scholar 

Sleijfer, S. Bleomycin-induced pneumonitis. Chest 120, 617–624 (2001).

Article  CAS  PubMed  Google Scholar 

Ehrlich, Y., Margel, D., Lubin, M. A. & Baniel, J. Advances in the treatment of testicular cancer. Transl. Androl. Urol. 4, 381–390 (2015).

PubMed  PubMed Central  Google Scholar 

Huddart, R. A. et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J. Clin. Oncol. 21, 1513–1523 (2003).

Article  CAS  PubMed  Google Scholar 

Van Den Belt-Dusebout, A. W. et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J. Clin. Oncol. 25, 4370–4378 (2007).

Article  PubMed  Google Scholar 

Fosså, S. D., Aass, N., Winderen, M., Börmer, O. P. & Olsen, D. R. Long-term renal function after treatment for malignant germ-cell tumours. Ann. Oncol. 13, 222–228 (2002).

Article  PubMed  Google Scholar 

Hansen, S. W., Groth, S., Daugaard, G., Rossing, N. & Rørth, M. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer. J. Clin. Oncol. 6, 1728–1731 (1988).

Article  CAS  PubMed  Google Scholar 

Kennedy, I. C., Fitzharris, B. M., Colls, B. M. & Atkinson, C. H. Carboplatin is ototoxic. Cancer Chemother. Pharmacol. 26, 232–234 (1990).

Article  CAS  PubMed  Google Scholar 

Hjelle, L. V. et al. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors. Urol. Oncol. 34, 487.e13–487.e20 (2016).

Article  CAS  PubMed  Google Scholar 

Kerns, S. L. et al. Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study. J. Clin. Oncol. 36, 1505–1512 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brydøy, M. et al. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur. Urol. 58, 134–141 (2010).

Article  PubMed  Google Scholar 

Brydøy, M. et al. Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. Br. J. Cancer 107, 1833–1839 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Brydøy, M. et al. Paternity following treatment for testicular cancer. J. Natl Cancer Inst. 97, 1580–1588 (2005).

Article  PubMed  Google Scholar 

Loren, A. W. et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J. Clin. Oncol. 31, 2500–2510 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Giannatempo, P. et al. Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. Ann. Oncol. 26, 657–668 (2015).

Article  CAS  PubMed  Google Scholar 

Hanna, N. et al. in Holland-Frei Cancer Medicine 6th edn (eds Kufe, D. W. et al.) (BC Decker, 2003).

Travis, L. B. et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J. Natl Cancer Inst. 97, 1354–1355 (2005).

Article  PubMed  Google Scholar 

Hellesnes, R. et al. Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort [abstract]. J. Clin. Oncol. 39 (Suppl. 15), 5006 (2021).

Article  Google Scholar 

Honecker, F. et al. ESMO consensus conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann. Oncol. 29, 1658–1686 (2018).

Article  CAS  PubMed  Google Scholar 

Spinner, M. A. & Advani, R. H. Risk-adapted therapy for advanced-stage Hodgkin lymphoma. Hematology Am. Soc. Hematol. Educ. Program 2018, 200–206 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Grimison, P. S. et al. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial. J. Natl Cancer Inst. 102, 1253–1262 (2010).

Article  CAS  PubMed  Google Scholar 

Nichols, C. & Kollmannsberger, C. Alternatives to standard BEP × 3 in good-prognosis germ cell tumors – you bet your life. J. Natl Cancer Inst. 102, 1214–1215 (2010).

Article  PubMed  Google Scholar 

Newton, C. et al. A multicentre retrospective cohort study of ovarian germ cell tumours: evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. Eur. J. Cancer 113, 19–27 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tookman, L. et al. Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma. Acta Oncol. 52, 987–993 (2013).

Article  CAS  PubMed  Google Scholar 

Powles, T. et al. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann. Oncol. 19, 443–447 (2008).

Article  CAS  PubMed  Google Scholar 

Horwich, A. et al. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J. Clin. Oncol. 7, 1150–1156 (1989).

Article  CAS  PubMed  Google Scholar 

Shamash, J. et al. A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma. Eur. J. Cancer 115, 128–135 (2019).

留言 (0)

沒有登入
gif